Fundraising FoxSV Health Investors — 2022 Investments
8 investments dated 2022 · listed companies and verified rows first · show all
EyeBio (Eyebiotech Limited), a subsidiary of Merck, develops therapies for retinal diseases such as diabetic macular edema and neovascular age-related macular degeneration, targeting vascular leakage through pathways like Wnt signaling.
BiotechHealthtechHolborn, London
David R. Guyer(Founder, CEO & President)Anthony P. Adamis(Chief Scientific Officer, Co-founder, Director & Chair of Advisory Board)James Allister John Costine(Director)Michael Jay Ross(Executive Officer)Catherine Elizabeth Bingham(Director)
Co-investorsJeito CapitalSamsara BioCapitalOmega Funds
Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health.
BiotechFemTechMedical DevicesCambridge, US
Alison Burklund(Executive Officer, Director)inAmogha Tadimety(Executive Officer, Director)in
BoardAaron Sandoski(Director)inJeff Crowe(Director)in
Co-investorsAlumni VenturesGingerbread CapitalNorwest Venture PartnersService Provider CapitalUndeterred CapitalGreen D Ventures+2 more
Nimbus Engineering is a hardware company and online retailer developing energy transfer technology, including its patented Power Relay, a portable power outlet for home, office, and outdoor use.
CleantechDeep TechEnergyHardwareSan Francisco, US
Michael Gorman(Founder)in
Co-investorsFoothill VenturesAccess BiotechnologyAtlas VentureBain Capital Life SciencesBiotechnology Value FundCommodore Capital+2 more
FuseBase is an enterprise platform for deploying and managing AI agents across teams with role-based access controls, audit trails, and integrations to CRM, Slack, Teams, and email systems.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSCleveland, US
Pavel Sher(CEO)Aaron Adsit(CRO)Denis Kibalko(CTO)
Co-investorsPre-Seed to SucceedYellow Rocks!Access BiotechnologyAtlas VentureBain Capital Life SciencesBiotechnology Value Fund+3 more
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSeroba Life SciencesBek VenturesEnterprise IrelandEQT Life Sciences
Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.
BiotechHealthtech
Pete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDavid Mantusin
Co-investorsAdjuvant CapitalAsahi Kasei Corporate Venture CapitalDementia Discovery FundF-Prime CapitalJeito CapitalLongwood Fund+4 more
Ria Health provides telemedicine-based treatment for alcohol and opioid use disorders, delivered by a team of physicians, nurse practitioners, and counselors.
Digital HealthHealthtechMental HealthWellness & FitnessSan Francisco, US
Bill Stapleton(CEO)in
Co-investorsSOSV
Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.
BiotechHealthtech
Shelley Force Aldred(Co-Founder & Chief Executive Officer)inNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)
Co-investorsCanaan PartnersDementia Discovery FundRed Tree VentureJohnson & Johnson Innovation – JJDCNovo Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.